Ivermectin + Fenbendazole (Wormentel Duo 156)

What Is Ivermectin + Fenbendazole?

Ivermectin + Fenbendazole is a combination antiparasitic tablet that brings together two well-known antiparasitic compounds from different drug classes into a single formulation. This combination is used to address parasitic infections requiring broader antiparasitic coverage — particularly mixed parasitic infections where multiple parasite types may be present.

• Ivermectin (6mg) — an avermectin-class antiparasitic that acts on the parasite's nervous system
• Fenbendazole (150mg) — a benzimidazole-class antiparasitic that disrupts the parasite's energy metabolism

Together, these two ingredients form a synergistic antiparasitic pair — one paralyzing the parasite through nerve action and the other depriving it of energy by blocking nutrient absorption. This dual approach makes the combination highly practical for parasite management protocols where a wider spectrum of activity is required.

Wormentel Duo 156 is the branded formulation of this combination produced by Kachhela Medex Pvt. Ltd. Any human use must be strictly under qualified medical supervision, as Fenbendazole is not FDA-approved for human medical use.

Manufacturer Details

Ivermectin + Fenbendazole (Wormentel Duo 156) Tablets are manufactured by Kachhela Medex Pvt. Ltd., a licensed pharmaceutical company producing antiparasitic and other pharmaceutical products in certified manufacturing facilities.

Each batch undergoes comprehensive quality evaluation to confirm the accurate strength of both active ingredients per tablet along with overall purity and stability. The tablets are packaged in protective blister strips of 10 tablets per strip, providing moisture and environmental protection during storage and transit.

Powerful Combination

Feature	Ivermectin 6mg	Fenbendazole 150mg
Drug Class	Avermectin Antiparasitic	Benzimidazole Antiparasitic
Mechanism of Action	Binds glutamate-gated chloride channels, causing parasite paralysis.	Binds beta-tubulin and disrupts parasite glucose absorption.
Primary Effect	Nerve and muscle paralysis	Energy depletion and cellular breakdown
Speed of Action	Rapid neuromuscular paralysis	Progressive metabolic shutdown
Parasites Targeted	Strongyloides, roundworms, ectoparasites	Roundworms, hookworms, whipworms, certain tapeworms
FDA Approval Status	Approved for certain human parasitic infections	Not FDA-approved for human use (veterinary medicine)
Recognition	WHO Essential Medicine	Widely used veterinary antiparasitic
Combined Advantage	✔ Dual-action antiparasitic therapy providing broader parasite coverage through complementary mechanisms. Ivermectin targets the parasite's nervous system, while Fenbendazole disrupts energy metabolism, making the combination useful where broader antiparasitic coverage is clinically appropriate.

How Does Ivermectin + Fenbendazole Work?

This combination tablet works through two distinct antiparasitic mechanisms operating simultaneously within the parasite.

Ivermectin Mechanism:

• The result is hyperpolarization of parasite nerve and muscle cells — causing complete paralysis
• Paralyzed parasites cannot feed, move, or reproduce and are eliminated naturally by the body

Fenbendazole Mechanism:

• Without functional microtubules, the parasite cannot absorb glucose for energy
• Progressive energy depletion causes the parasite to break down and be eliminated

Combined Advantage:

The two mechanisms complement each other — Ivermectin acts on the parasite's nervous system while Fenbendazole starves the parasite metabolically. This dual-mechanism approach delivers broader antiparasitic coverage and is particularly valuable when the specific parasite species is unclear or when multiple parasite types coexist.

Both mechanisms are highly selective for parasitic organisms and have minimal impact on mammalian cells.

Commonly Prescribed Uses

• Roundworm infections — Ascaris, Toxocara, and Toxascaris species
• Hookworm infections — Ancylostoma and Uncinaria species
• Whipworm infections — Trichuris species
• Strongyloidiasis — caused by Strongyloides stercoralis
• Certain tapeworm species — Taenia species in appropriate contexts
• Giardia infections — in certain veterinary treatment protocols
• Broad-spectrum parasite management — where dual-mechanism coverage is clinically indicated

All prescribing or recommending decisions are made entirely by a qualified professional based on species involved, clinical evaluation, and individual health factors.

Benefits of Ivermectin + Fenbendazole

• Powerful dual-action combination — two distinct antiparasitic mechanisms working together in one tablet
• Broader antiparasitic spectrum than either Ivermectin or Fenbendazole used individually
• Highly effective for mixed parasitic infections where multiple parasite types coexist
• Two clinically proven antiparasitic ingredients with decades of established use worldwide
• Convenient single-tablet combination — eliminates the need to administer separate medicines
• Kachhela Medex Pvt. Ltd. quality manufacturing under GMP-compliant standards
• Available through MayoPills with discreet packaging and tracked delivery in 10 to 15 business days

How to Take

• Take Ivermectin + Fenbendazole exactly as recommended by your professional
• Take doses at the exact intervals specified by the supervising professional
• Complete the entire recommended course without stopping early — even if symptoms improve
• Never share this medicine with another person or animal without professional guidance

Dosage Information

The appropriate dose depends on several individual factors:

• Species being treated
• Body weight — combination antiparasitic dosing is often weight-based
• Type of parasitic infection(s) present
• Severity of infestation
• Age and overall health status
• Other medicines currently being taken

Possible Side Effects

Not all patients experience side effects. Most reported effects are mild and temporary, and many may be related to the body's response to dying parasites rather than the medicines themselves.

Commonly reported:

• Nausea
• Stomach discomfort or abdominal pain
• Diarrhea
• Loss of appetite
• Dizziness
• Mild lethargy
• Skin itching

Less commonly reported:

• Headache
• Fever
• Vomiting
• Temporary swelling
• Mild allergic skin reactions

Seek immediate professional attention if:

• Severe allergic reaction — swelling, difficulty breathing, or widespread hives
• Neurological symptoms — confusion, difficulty walking, seizures, or loss of consciousness
• Severe skin reactions — blistering, peeling, or widespread rash
• Signs of liver problems — jaundice, dark urine, or persistent nausea
• Suspected overdose — seek immediate emergency care

Warnings & Precautions

• Known allergy to Ivermectin, Fenbendazole, avermectin-class, or benzimidazole-class compounds — do not use
• Young children or young animals — use only under direct professional supervision
• Pregnancy — use only when clearly necessary and under direct supervision
• Breastfeeding — consult your provider before use
• Liver disease — inform your provider as both ingredients are metabolized by the liver
• Heart or nervous system conditions — disclose to your provider before starting treatment
• Alcohol — avoid during treatment as it may increase adverse effect risk
• Fenbendazole is not FDA-approved for human use — any human use must only be under direct qualified medical supervision

Drug Interactions

Ivermectin + Fenbendazole may interact with:

• Warfarin and anticoagulants — potential increased bleeding risk
• CNS depressants — enhanced sedative effects with Ivermectin
• Barbiturates and valproic acid — potential interaction with Ivermectin
• Cimetidine — may affect metabolism of Fenbendazole
• Salicylanilide compounds — potential enhanced adverse effects with Fenbendazole
• Other antiparasitic medicines — combined use requires professional assessment
• Alcohol — avoid concurrent use

Always inform your veterinarian or healthcare professional about every medicine, supplement, and product currently in use before starting Ivermectin + Fenbendazole.

Storage

• Store at room temperature below 25°C or 77°F
• Store in original blister strip packaging until ready for use
• Keep out of reach of children and pets at all times
• Do not use past the printed expiry date
• Dispose of unused or expired tablets following local pharmaceutical waste disposal regulations
• Do not flush down drains or discard in regular household waste

Frequently Asked Questions

Q: What is Ivermectin + Fenbendazole (Wormentel Duo 156) used for?

A: This combination is used under professional guidance for mixed parasitic worm infections and for broader antiparasitic coverage where a single agent may not be sufficient. It combines Ivermectin 6mg with Fenbendazole 150mg per tablet in a dual-action formulation.

Q: Why is Ivermectin + Fenbendazole considered a powerful combination?

A: The combination brings together two independent antiparasitic mechanisms. Ivermectin paralyzes parasites through nerve action while Fenbendazole cuts off their energy supply by blocking glucose absorption. This dual attack covers a broader range of parasites than either agent alone and is highly effective for mixed parasitic infections.

Q: Is Ivermectin + Fenbendazole approved for human use?

A: Ivermectin holds FDA approval for certain human parasitic infections. Fenbendazole is not FDA-approved for human medical use. This combination product is primarily used in veterinary contexts, and any human use must be strictly under direct qualified medical supervision.

Q: What is Wormentel Duo 156?

A: Wormentel Duo 156 is the branded name of this Ivermectin + Fenbendazole combination tablet produced by Kachhela Medex Pvt. Ltd. Each tablet contains the same active ingredients — Ivermectin 6mg and Fenbendazole 150mg.

Q: Can this combination be used during pregnancy?

A: Use during pregnancy should only be considered when clearly necessary and under direct professional supervision. Always inform your provider if pregnancy is present or planned before starting treatment.

Q: Should Ivermectin + Fenbendazole be taken with food?

A: Follow your veterinary or healthcare professional's specific instructions regarding food and timing. Absorption characteristics may vary depending on individual clinical context.

Q: Why might a follow-up dose be recommended?

A: For certain parasitic infections, eggs may hatch after the initial treatment. A follow-up dose may be recommended by the supervising professional to eliminate newly hatched parasites and prevent reinfection cycles.

Q: What side effects should be monitored?

A: Common effects include mild digestive upset, nausea, dizziness, and lethargy — most of which resolve without intervention. Seek immediate professional attention for severe allergic reactions, neurological symptoms, or any unexpected serious symptom during or after treatment.

Q: How should Ivermectin + Fenbendazole Tablets be stored?

A: Store below 25°C away from sunlight and moisture in the original blister packaging. Keep out of reach of children and pets at all times, and do not use past the printed expiry date.

Q: Who manufactures Ivermectin + Fenbendazole (Wormentel Duo 156)?

A: This combination product is manufactured by Kachhela Medex Pvt. Ltd. in certified pharmaceutical manufacturing facilities under GMP-compliant quality control standards.